the author analysed the experimental investigations carried our by himself on the effects of epileptogenic foci and/or diphenylhydantoin on the process of learning , eeg tracings , and histological findings in the brain and internal organs , and believes that prophylactic administration of diphenylhydantoin in moderate therapeutic doses ( 20 mg daily ) and for a relatively short time period ( 1 year ) is associated with a much lower possibility of side effects than the risk of development of post-traumatic epilepsy .
C0031507
diphenylhydantoin
C0014557
post-traumatic